Cargando…
Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia
Background: Chinese medicine (CM) is widely used for treating hyperlipidemias, especially in China. However, the heterogeneity of outcomes measured and reported across trials exacerbates the obstacles of evidence synthesis and effectiveness comparison. In this study, we develop a core outcome set (C...
Autores principales: | Li, Geng, Han, Ruxue, Lin, Mingjun, Wen, Zehuai, Chen, Xiankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108338/ https://www.ncbi.nlm.nih.gov/pubmed/35586053 http://dx.doi.org/10.3389/fphar.2022.847101 |
Ejemplares similares
-
Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set
por: Li, Geng, et al.
Publicado: (2021) -
A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey
por: Li, Geng, et al.
Publicado: (2019) -
Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020) -
Development of CORE-CM core outcome domain sets for trials of Chinese medicine for lumbar spinal stenosis
por: Sun, Ya-Nan, et al.
Publicado: (2023) -
Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
por: Cha, Jiyun, et al.
Publicado: (2022)